注射用静菌水市場レポート：2030年までの動向、予測、競合分析

注射用静菌水の動向と予測

世界の注射用静菌水市場は、2024年から2030年までのCAGRが6.9%で、2030年までに推定16億米ドルに達すると予想されています。この市場の主な促進要因は、病原性細菌の迅速な増殖抑制と、バイオ医薬品およびジェネリック注射薬産業の急成長です。世界の注射用静菌水市場の将来は、病院・診療所市場でのビジネスチャンスにより有望視されています。

注射用静菌水市場の洞察

Lucintelの予測によると、予測期間中、薬剤の希釈は、薬を服用するために多くの注射を採用する人々の増加により、最大のセグメントであり続けると予想されます。

この市場の中では、ヘルスケア産業における薬剤や注射の使用量の増加により、病院が引き続き大きなセグメントとなります。

北米は、静脈内、皮下、筋肉内投与による薬剤投与を必要とする病院患者の増加により、予測期間中も最大の地域です。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.今後成長が加速するセグメントとその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の注射用静菌水市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の注射用静菌水市場動向（2018-2023）と予測（2024-2030）
• 流通チャネル別の世界の注射用静菌水市場
  • 病院薬局
  • オンライン薬局
  • その他
• 用途別の世界の注射用静菌水市場
  • 薬剤の希釈
  • 臨床薬理学
  • 抗菌用途
  • その他
• 最終用途別の世界の注射用静菌水市場
  • 病院
  • クリニック
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の注射用静菌水市場
• 北米の注射用静菌水市場
• 欧州の注射用静菌水市場
• アジア太平洋の注射用静菌水市場
• その他地域の注射用静菌水市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 流通チャネル別の世界の注射用静菌水市場の成長機会
  • 用途別の世界の注射用静菌水市場の成長機会
  • 最終用途別の世界の注射用静菌水市場の成長機会
  • 地域別の世界の注射用静菌水市場の成長機会
• 世界の注射用静菌水市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の注射用静菌水市場の生産能力拡大
  • 世界の注射用静菌水市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Acella Pharmaceuticals
• Merck
• Abbott
• Procter and Gamble
• Pfizer
• Reckitt Benckiser
• GlaxoSmithKline

Bacteriostatic Water For Injection Trends and Forecast

The future of the global bacteriostatic water for injection market looks promising with opportunities in the hospital and clinic markets. The global bacteriostatic water for injection market is expected to reach an estimated $1.6 billion by 2030 with a CAGR of 6.9% from 2024 to 2030. The major drivers for this market are swift inhibition of pathogenic bacteria proliferation and rapid growth of the biopharmaceutical and generic injectable medicine industries.

A more than 150-page report is developed to help in your business decisions.

Bacteriostatic Water For Injection by Segment

The study includes a forecast for the global bacteriostatic water for injection by distribution channel, application, end use, and region.

Bacteriostatic Water for Injection Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Online Pharmacies
• Others

Bacteriostatic Water for Injection Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Medication Dilution
• Clinical Pharmacology
• Anti-Bacterial Applications
• Others

Bacteriostatic Water for Injection Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Others

Bacteriostatic Water for Injection Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Bacteriostatic Water For Injection Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bacteriostatic water for injection companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bacteriostatic water for injection companies profiled in this report include-

• Acella Pharmaceuticals
• Merck
• Abbott
• Procter and Gamble
• Pfizer
• Reckitt Benckiser
• GlaxoSmithKline

Bacteriostatic Water for Injection Market Insights

Lucintel forecasts that medication dilution will remain the largest segment over the forecast period due to increasing number of people adopting more injections to take their medications.

Within this market, hospitals will remain the larger segment due to increasing usage of medications and injections in the healthcare industry.

North America will remain the largest region over the forecast period due to growing number of patients in hospitals, which requires drug administration via intravenous, subcutaneous, and intramuscular methods.

Features of the Global Bacteriostatic Water for Injection Market

Market Size Estimates: Bacteriostatic water for injection market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bacteriostatic water for injection market size by distribution channel, application, end use, and region in terms of value ($B).

Regional Analysis: Bacteriostatic water for injection market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different distribution channels, applications, end uses, and regions for the bacteriostatic water for injection market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bacteriostatic water for injection market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the bacteriostatic water for injection market size?

Answer: The global bacteriostatic water for injection market is expected to reach an estimated $1.6 billion by 2030.

Q2. What is the growth forecast for bacteriostatic water for injection market?

Answer: The global bacteriostatic water for injection market is expected to grow with a CAGR of 6.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bacteriostatic water for injection market?

Answer: The major drivers for this market are swift inhibition of pathogenic bacteria proliferation and rapid growth of the biopharmaceutical and generic injectable medicine industries.

Q4. What are the major segments for bacteriostatic water for injection market?

Answer: The future of the bacteriostatic water for injection market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key bacteriostatic water for injection market companies?

Answer: Some of the key bacteriostatic water for injection companies are as follows:

• Acella Pharmaceuticals
• Merck
• Abbott
• Procter and Gamble
• Pfizer
• Reckitt Benckiser
• GlaxoSmithKline

Q6. Which bacteriostatic water for injection market segment will be the largest in future?

Answer: Lucintel forecasts that medication dilution will remain the largest segment over the forecast period due to increasing number of people adopting more injections to take their medications.

Q7. In bacteriostatic water for injection market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing number of patients in hospitals, which requires drug administration via intravenous, subcutaneous, and intramuscular methods.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bacteriostatic water for injection market by distribution channel (hospital pharmacies, online pharmacies, and others), application (medication dilution, clinical pharmacology, anti-bacterial applications, and others), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bacteriostatic Water for Injection Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Bacteriostatic Water for Injection Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Bacteriostatic Water for Injection Market by Distribution Channel
  • 3.3.1: Hospital Pharmacies
  • 3.3.2: Online Pharmacies
  • 3.3.3: Others
• 3.4: Global Bacteriostatic Water for Injection Market by Application
  • 3.4.1: Medication Dilution
  • 3.4.2: Clinical Pharmacology
  • 3.4.3: Anti-bacterial Applications
  • 3.4.4: Others
• 3.5: Global Bacteriostatic Water for Injection Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Bacteriostatic Water for Injection Market by Region
• 4.2: North American Bacteriostatic Water for Injection Market
  • 4.2.1: North American Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
  • 4.2.2: North American Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others
• 4.3: European Bacteriostatic Water for Injection Market
  • 4.3.1: European Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
  • 4.3.2: European Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others
• 4.4: APAC Bacteriostatic Water for Injection Market
  • 4.4.1: APAC Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
  • 4.4.2: APAC Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others
• 4.5: ROW Bacteriostatic Water for Injection Market
  • 4.5.1: ROW Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
  • 4.5.2: ROW Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by Distribution Channel
  • 6.1.2: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by Application
  • 6.1.3: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by End Use
  • 6.1.4: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by Region
• 6.2: Emerging Trends in the Global Bacteriostatic Water for Injection Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bacteriostatic Water for Injection Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bacteriostatic Water for Injection Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Acella Pharmaceuticals
• 7.2: Merck
• 7.3: Abbott
• 7.4: Procter and Gamble
• 7.5: Pfizer
• 7.6: Reckitt Benckiser
• 7.7: GlaxoSmithKline